We are live on ! Find out more
CVSA

Covista Inc

127.64 USD
-6.52
4.86%
At close Updated Sep 3, 4:00 PM EDT
Pre-market
After hours
127.64
0.00
0%
1 day
-4.86%
5 days
-9.27%
1 month
0.12%
3 months
3.72%
6 months
24.28%
Year to date
22.18%
1 year
-5.05%
5 years
244.04%
10 years
457.14%
 

About: Covista Inc is America's healthcare educator across five accredited institutions: Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. It delivers education to its students at multiple campuses and online. Its segments are Chamberlain, Walden, and Medical and Veterinary. Walden generates maximum revenue and includes the operations of Walden, which offers degree and certificate programs, including those in nursing, education, counseling, business, information technology, psychology, public health, social work and human services, public administration and public policy, and criminal justice. The Company generates maximum revenue from Domestic operations.

Employees: 5,037

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 47.6%
Neutral 52.4%
Negative 0%
Positive
Zacks Investment Research
15 hours ago
Here's Why Covista (CVSA) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Covista (CVSA) is a Strong Momentum Stock
Positive
Zacks Investment Research
1 day ago
Here's Why Covista (CVSA) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why Covista (CVSA) is a Strong Growth Stock
Positive
Zacks Investment Research
7 days ago
Here's Why Covista (CVSA) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why Covista (CVSA) is a Strong Value Stock
Positive
Zacks Investment Research
17 days ago
Here's Why Covista (CVSA) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Covista (CVSA) is a Strong Growth Stock
Positive
Seeking Alpha
20 days ago
Covista: Strong Secular Growth And Operating Leverage
Covista is rated BUY, driven by secular healthcare education demand and 12 consecutive quarters of enrollment growth. CVSA's Q4 saw revenue up 9.7% and adjusted EPS up 25.9%, with all segments showing positive operating leverage and margin expansion. Strong cash flows, a declining leverage ratio, and $238m in share repurchases reinforce balance sheet strength and shareholder returns.
Covista: Strong Secular Growth And Operating Leverage
Neutral
The Motley Fool
21 days ago
Covista SVP Sells 4,526 Shares for $615,000
The disposition of 4,526 shares on August 7, 2026, realized a total value of ~$615,000. The transaction resulted in a 14% reduction in the insider's direct equity holdings.
Covista SVP Sells 4,526 Shares for $615,000
Positive
Zacks Investment Research
24 days ago
Why Covista (CVSA) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Covista (CVSA) is a Top Value Stock for the Long-Term
Positive
Zacks Investment Research
27 days ago
Covista Q4 Earnings & Revenues Top Estimates, Enrollments Up Y/Y
CVSA posts double-digit profit growth, record Walden enrollment and raises fiscal 2027 targets as strong execution continued across all three segments.
Covista Q4 Earnings & Revenues Top Estimates, Enrollments Up Y/Y
Neutral
Seeking Alpha
28 days ago
Covista Inc. (CVSA) Q4 2026 Earnings Call Transcript
Covista Inc. (CVSA) Q4 2026 Earnings Call Transcript
Covista Inc. (CVSA) Q4 2026 Earnings Call Transcript
Positive
Zacks Investment Research
28 days ago
Covista (CVSA) Q4 Earnings and Revenues Top Estimates
Covista (CVSA) came out with quarterly earnings of $2.09 per share, beating the Zacks Consensus Estimate of $1.9 per share. This compares to earnings of $1.66 per share a year ago.
Covista (CVSA) Q4 Earnings and Revenues Top Estimates
Price charts implemented using Lightweight Charts™